The Institute for Neurological Research® in Los Angeles and Newport Beach

INR 100 UCLA Medical Plaza, Suites 205-210 Los Angeles, California 90095 (310) 824-6199 Edward Tobinick MD, Medical Director

New Orange County office: 361 Hospital Road, Suite 428 Newport Beach, California 92663

Rapid improvement in Alzheimer's, beginning within minutes*

Video1 Video2 (Australia)Video3 Video4 Video5 Video6 Video7 Video8 Video9 Video10 Video11 Video12 Video13 (Mexico)Video14 Video15 (Espanol)Video16

Families are flying to the INR® in Los Angeles from around the world to begin the INR's unique treatment for Alzheimer's and PPA (see videos above)

*see: Edward Tobinick MD, Perispinal etanercept for neuroinflammatory disorders Drug Discovery Today 2009 Feb;14(3-4):168-77. (download abstracts PDF)

Perispinal etanercept for Alzheimer's is a patented[1], off-label treatment method invented at the INR. It is available in the U.S. exclusively through INR trained and licensed physicians. Patients and physicians are coming to the INR from around the world for treatment and physician training.

as seen in Nature Clinical Practice Neurology, in a university press release, on Medscape, the BBC, New Scientist, CNN, Fox News, ABC News, Bloomberg News, Reuters Health, the Times Online (U.K.), the Daily Telegraph(U.K.), and UPI.

Appointments and information (310) 824-6199

In the News: Epidural etanercept for lumbosacral radiculopathy, an off-label treatment method invented at the INR, has positive results in randomized, double-blind, placebo-controlled clinical trial conducted at Walter Reed Army Medical Center (link)

Review article published: Edward Tobinick MD.Tumour necrosis factor modulation for treatment of Alzheimer's disease: rationale and current evidence. CNS Drugs. September 2009: 23(9):713-25

Recent and upcoming conference presentations by Edward Tobinick MD, Director of the INR:

TNF antagonists for neurological disorders: from concept to the clinic, scheduled presentation at GTC Bio's 5th Modern Drug Discovery & Development Conference, October 14-1, 2009, San Diego, California

TNF Modulation for treatment of Alzheimer's Disease, at the Targeting Alzheimer's with Novel Therapeutics Conference at the World Pharmaceutical Congress, Philadelphia, June 11, 2009 (more information)

Perispinal etanercept for Alzheimer's disease, at the 3rd International Scientific Conference Restauracion Neurologica 2009, Havana, Cuba March 11, 2009

<Map and Directions><Appointments><Physician Training Program><Terms of Use><Memory Disorders Program-detailed brochure (PDF)><Videos>

Copyright ©2009, the Institute for Neurological Research® (INR®), a private medical group, inc., all rights reserved. [1]U.S. patents 6,537,549; 6,982,089; 7,214,658; and Australian patent 758,523; and additional issued and pending U.S. and foreign patents. These patents are assigned to TACT IP LLC. Please see the medical and legal disclaimer.